BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coopersmith CM, Antonelli M, Bauer SR, Deutschman CS, Evans LE, Ferrer R, Hellman J, Jog S, Kesecioglu J, Kissoon N, Martin-Loeches I, Nunnally ME, Prescott HC, Rhodes A, Talmor D, Tissieres P, De Backer D. The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness. Crit Care Med 2021;49:598-622. [PMID: 33591008 DOI: 10.1097/CCM.0000000000004895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Hoteit R, Yassine HM. Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences. Vaccines (Basel) 2022;10:919. [PMID: 35746526 DOI: 10.3390/vaccines10060919] [Reference Citation Analysis]
2 Sessa R, Anastasi E, Brandolino G, Brunelli R, Di Pietro M, Filardo S, Masciullo L, Terrin G, Viscardi MF, Porpora MG. What is the Hidden Biological Mechanism Underlying the Possible SARS-CoV-2 Vertical Transmission? A Mini Review. Front Physiol 2022;13:875806. [DOI: 10.3389/fphys.2022.875806] [Reference Citation Analysis]
3 Zhou Y, Xu X, Wei H. Complex Pathophysiological Mechanisms and the Propose of the Three-Dimensional Schedule For Future COVID-19 Treatment. Front Immunol 2021;12:716940. [PMID: 34745094 DOI: 10.3389/fimmu.2021.716940] [Reference Citation Analysis]
4 Bhinder KK, Siddiqi AR, Tahir MJ, Maqsood H, Ullah I, Yousaf Z. Bilateral basal ganglia ischemia associated with COVID-19: a case report and review of the literature. J Med Case Rep 2021;15:563. [PMID: 34809725 DOI: 10.1186/s13256-021-03165-x] [Reference Citation Analysis]
5 Rosén J, von Oelreich E, Fors D, Jonsson Fagerlund M, Taxbro K, Skorup P, Eby L, Campoccia Jalde F, Johansson N, Bergström G, Frykholm P; PROFLO Study Group. Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial. Crit Care 2021;25:209. [PMID: 34127046 DOI: 10.1186/s13054-021-03602-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Reyes LF, Murthy S, Garcia-gallo E, Irvine M, Merson L, Martin-loeches I, Rello J, Taccone FS, Fowler RA, Docherty AB, Kartsonaki C, Aragao I, Barrett PW, Beane A, Burrell A, Cheng MP, Christian MD, Cidade JP, Citarella BW, Donnelly CA, Fernandes SM, French C, Haniffa R, Harrison EM, Ho AYW, Joseph M, Khan I, Kho ME, Kildal AB, Kutsogiannis D, Lamontagne F, Lee TC, Bassi GL, Lopez Revilla JW, Marquis C, Millar J, Neto R, Nichol A, Parke R, Pereira R, Poli S, Povoa P, Ramanathan K, Rewa O, Riera J, Shrapnel S, Silva MJ, Udy A, Uyeki T, Webb SA, Wils E, Rojek A, Olliaro PL. Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study. ERJ Open Res 2022;8:00552-2021. [DOI: 10.1183/23120541.00552-2021] [Reference Citation Analysis]
7 Marais C, Claude C, Semaan N, Charbel R, Barreault S, Travert B, Piloquet JE, Demailly Z, Morin L, Merchaoui Z, Teboul JL, Durand P, Miatello J, Tissières P; COVID-19 Immune Suppression (CLOVIS) Study Group. Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study. Ann Intensive Care 2021;11:111. [PMID: 34259942 DOI: 10.1186/s13613-021-00896-4] [Reference Citation Analysis]
8 Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E; Awake Prone Positioning Meta-Trial Group. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med 2021:S2213-2600(21)00356-8. [PMID: 34425070 DOI: 10.1016/S2213-2600(21)00356-8] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 S K SR, P A A, B S, Kalala KP, Pm A, Sabarathinam S. Drug interaction risk between cardioprotective drugs and drugs used in treatment of COVID-19: A evidence-based review from six databases. Diabetes Metab Syndr 2022;16:102451. [PMID: 35279008 DOI: 10.1016/j.dsx.2022.102451] [Reference Citation Analysis]
10 Deana C, Vetrugno L, Fabris M, Curcio F, Sozio E, Tascini C, Bassi F. Pericardial Cytokine "Storm" in a COVID-19 Patient: the Confirmation of a Hypothesis. Inflammation 2021. [PMID: 34533672 DOI: 10.1007/s10753-021-01563-3] [Reference Citation Analysis]
11 Melamed R, Paz F, Jepsen S, Smith C, Saavedra R, Mulder M, Masood A, Huelster J, Kirkland L, Guenther A, Boland L. Prognostic factors and outcomes in COVID-19 patients requiring prolonged mechanical ventilation: a retrospective cohort study. Ther Adv Respir Dis 2022;16:175346662210864. [DOI: 10.1177/17534666221086415] [Reference Citation Analysis]
12 Reyes LF, Bastidas A, Narváez PO, Parra-Tanoux D, Fuentes YV, Serrano-Mayorga CC, Ortíz V, Caceres EL, Ospina-Tascon G, Díaz AM, Jibaja M, Vera M, Silva E, Gorordo-Delsol LA, Maraschin F, Varón-Vega F, Buitrago R, Poveda M, Saucedo LM, Estenssoro E, Ortíz G, Nin N, Calderón LE, Montaño GS, Chaar AJ, García F, Ramírez V, Picoita F, Peláez C, Unigarro L, Friedman G, Cucunubo L, Bruhn A, Hernández G, Martin-Loeches I; LIVEN-Covid-19 Investigators. Clinical characteristics, systemic complications, and in-hospital outcomes for patients with COVID-19 in Latin America. LIVEN-Covid-19 study: A prospective, multicenter, multinational, cohort study. PLoS One 2022;17:e0265529. [PMID: 35358238 DOI: 10.1371/journal.pone.0265529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nunnally ME, Ferrer R, Martin GS, Martin-Loeches I, Machado FR, De Backer D, Coopersmith CM, Deutschman CS; Surviving Sepsis Campaign Reasearch Committee. The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis. Intensive Care Med Exp 2021;9:34. [PMID: 34212256 DOI: 10.1186/s40635-021-00400-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Morrell ED, Wurfel MM. Prone positioning for non-intubated hypoxemic patients with COVID-19: cheap, easy, and makes sense, but does it work? Eur Respir J 2021:2102416. [PMID: 34649977 DOI: 10.1183/13993003.02416-2021] [Reference Citation Analysis]
15 Reyes LF, Rodriguez A, Bastidas A, Parra-Tanoux D, Fuentes YV, García-Gallo E, Moreno G, Ospina-Tascon G, Hernandez G, Silva E, Díaz AM, Jibaja M, Vera-Alarcon M, Díaz E, Bodí M, Solé-Violán J, Ferrer R, Albaya-Moreno A, Socias L, Estella Á, Loza-Vazquez A, Jorge-García R, Sancho I, Martin-Loeches I; LIVEN-COVID-19 Investigators and COVID-19 SEMICYUC Study Group. Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19. J Crit Care 2022;69:154014. [PMID: 35217370 DOI: 10.1016/j.jcrc.2022.154014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]